Drawing for Serial No. 79135301

USPTO serial 79135301

Serial No. 79135301

Reviewed by CopyMark Law Group

Reg. 4701774Status 404
Filing date
Status date
Registration date
Mar 17, 2015
Examiner
SETTLES LEWIS, SHAILA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79135301?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Felicia G. Traub, Esq.

Felicia G. Traub, Esq. Culhane Meadows PLLC13101 Preston Road, Ste. 110-1520Culhane Meadows Nat'l IP Support CtrDallas, TX 75240

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics, hair lotions, dentifrices, foot care preparations, cosmetical products, namely, liquids, creams, lotions, gels, foams, sprays, pastes, pumice pastes and powders for use on the skin, nails or scalp; make-up, facial cleansers, acne care preparations, skin creams, soaps for personal use, disinfectant soap, shampoo, personal deodorants for hygienic purposes, toothpastes, non-medicated foot-cleaning preparations, deodorants for feet, foot sprays for treating conditions of the nails, skin or scalp; emollient creams for treating conditions of the nails, skin or scalp, cotton sticks for cleansing for cosmetic purposes, cotton wool for cosmetic purposes, shaving creams, after-shave preparations, nail-care preparation, pre-moistened wipes for cosmetic purposes; All of the foregoing goods being non-medicatedSECTION 71 - CANCELLED—
005Pharmaceutical preparations, for the purpose of treating skin, scalp and nail conditions, fungal and bacterial infections, joint pain, muscle pain, cough, congestion, sinus, cold, flu and allergy symptoms, in the fields of dermatology, gerontology/aging, urology, gynecology, oncology, pediatrics, infectious diseases, pain relief, arthritis and osteoarthritis; sanitary preparations for medical purposes; cotton sticks for cleansing for medical purposes; medical and surgical plasters; disinfectant preparations, namely, pharmaceutical preparations with antimicrobial, emollient and/or ceratolytic properties in the form of liquids, gels, creams, lotions, sprays, foams or plaster patches for treating warts and other lesions of the epidermis and to loosen or dissolve dry, flakey, callused, and scaly skin or scalp; dermatological preparations for medical use; medical preparations for the treatment of dandruff; dandruff shampoo, dandruff conditioner; medical preparations for the treatment of psoriasis, atopical eczema; medical preparations for the treatment and prevention of acne, athletes foot and other dermatological foot conditions, vaginal fungal infection and other fungal infections; pre-moistened wipes for medical purposes, absorbent cotton wool for medical purposes, breast pads, tampons, plasters and dressings pre-treated with medicines for the treatment and prevention of fungal infections; medical preparations for the treatment of joint pain and muscle pain; medicated bath preparations; diagnostic preparations for medical purposes; mouthwashes for medical purposes; chewing gum for medical purposes; emollient creams for medical purposes; surgical compresses pre-treated with preparations for treating fungal infections; pharmaceutical preparations for treatment of actinic keratosis, genital warts, basal cell carcinoma and skin cancerSECTION 71 - CANCELLED—
010Medical instruments and medical devices for the application and/or dosing of medicines, medical devices for the application and/or dosing of medicines for the treatment or prevention of skin diseases and infections of the mucous membranes, syringes for medical purposes and for injections, implants consisting of artificial materials, vaginal rings, vaginal syringes, medical devices for retarding the effect of medical substances and for delivering medicines to the body for the treatment or prevention of skin diseases and infections of the mucous membranesSECTION 71 - CANCELLED—
035Advertising; business management; business administration; office functions; advertising of pharmaceutical products, cosmetic products and medical devices; commercial assistance in business management; demonstration of goods for promotional purposes; distribution of samples; import-export agency services; provision of commercial information; medical cost management; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; sponsoring office functions and industry meetings, seminars and lectures in the medical and cosmetical fields for advertising purposesSECTION 71 - CANCELLED—
036Insurance administration services in the nature of assisting others with collecting insurance premiums relating to acquisition of funds for covering procedures and pharmacological or cosmetical products to treat medical and cosmetic conditions; accepting and administering monetary charitable contributions to fund medical research; financing medical research of others; financial sponsorship of sporting and cultural events and activities; financial sponsorship of office functions and industry meetings, seminars and lectures in the medical and cosmetic fieldsSECTION 71 - CANCELLED—
041Education services, namely, providing seminars, demonstrations, presentations, and training in the fields of medicine and cosmetics; medical training and teaching; arranging and conducting educational conferences and symposia in the fields of medicine and cosmetics; publishing and issuing scientific papers in relation to pharmaceutical products, cosmetic products and medical devices; Educational services, namely, providing web-based training related to the purpose, function, efficacy and usage of pharmaceutical products, cosmetic products and medical devices to educate patients concerning their medical and cosmetic treatment regimensSECTION 71 - CANCELLED—
042Design and development of computer hardware and software; medical research laboratories, scientific research and design for others in the field of pharmaceuticals; conducting and evaluating clinical trials for others; diagnostic testing and analysis of pharmaceutical products used in the medical and cosmetic fields for efficacy and side-effects for scientific and research purposes; conducting and evaluating medical and scientific research and clinical trials in the fields of dermatology, gerontology, aging, orology, gynecology, oncology, pediatrics, infectious diseases, pain relief, arthritis and osteoarthritis for othersSECTION 71 - CANCELLED—
044Medical services; healthcare services for treatment of patients with disorders relating to the fields of dermatology, gerontology/aging, urology, gynecology, oncology, pediatrics, infectious diseases, pain relief, arthritis and osteoarthritis; advisory services relating to healthcare, in particular relating to treatment of medical and cosmetical conditions of patients by means of pharmaceutical products, cosmetical products and medical devicesSECTION 71 - CANCELLED—
045Legal services; legal services related to exploitation and licensing of intellectual property rightsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 26, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 28, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 26, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 1, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 31, 2022INPCINVALIDATION PROCESSED—
Jul 26, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 26, 2021C71TCANCELLED SECTION 71—
Jan 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 27, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 27, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 22, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 22, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 20, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 20, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 11, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 23, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 23, 2015FIMPFINAL DISPOSITION PROCESSED—
Jun 17, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 8, 2015GPNXNOTIFICATION PROCESSED BY IB—
Mar 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 30, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 30, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 10, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 10, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 25, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 25, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Nov 25, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 25, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 25, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 6, 2014DMCCDATA MODIFICATION COMPLETED—
Nov 6, 2014CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Oct 23, 2014CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 15, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 16, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 29, 2014CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 16, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2014ALIEASSIGNED TO LIE—
Mar 18, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2013RFNTREFUSAL PROCESSED BY IB—
Sep 21, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 20, 2013RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2013DOCKASSIGNED TO EXAMINER—
Sep 17, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 13, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 12, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance